高级检索
当前位置: 首页 > 详情页

加强皮肤管理以减少表皮生长因子受体(EGRF)突变的非小细胞肺癌(NSCLC)患者接受Amivantamab+Lazertinib一线治疗的皮疹和甲沟炎

文献详情

编号/登记号:
注册时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究设计:
研究类型:
药物名称:
药物类型:
伦理委员会审批: 批准本研究的伦理委员会名称: 伦理委员会审批时间:
研究负责人:
研究参与人:
研究单位: [1]四川大学华西医院 [2]惠州市中心人民医院 [3]复旦大学附属肿瘤医院 [4]中山大学附属第一医院 [5]西安交通大学第一附属医院 [6]四川省肿瘤医院 [7]河南省肿瘤医院 [8]哈尔滨医科大学附属肿瘤医院 [9]东南大学附属中大医院 [10]浙江大学医学院附属第一医院 [11]常州第二人民医院 [12]Linkou Chang Gung Memorial Hospital [13]National Taiwan University Hospital [14]Chang Kung Memorial Hospital [15]Taichung Veterans General Hospital [16]National Taiwan University Hospital Hsin-Chu Branch [17]IADT Instituto Argentino de Diagnostico y Tratamiento [18]Hospital Privado de la Comunidad [19]Hospital Italiano de La Plata [20]CIPREC [21]Hospital Italiano de Buenos Aires [22]Fundacao Doutor Amaral Carvalho [23]Hospital Nossa Senhora da Conceicao S A [24]Fundacao Antonio Prudente A C Camargo Cancer Center [25]Liga Paranaense de Combate ao Cancer [26]Oftalmologia e Oncologia Haeser e Correa LTDA [27]CTO Centro De Tratamento Oncologico LTDA [28]Associacao Feminina de Educacao e Combate ao Cancer Hospital Santa Rita de Cassia [29]Nucleo de Oncologia da Bahia [30]Servicos de Tratamento ao Cancer de Taubate LTDA - Instituto do Cancer Brasil Unidade Taubate [31]Santa Casa de Misericordia de Belo Horizonte [32]Instituto de Assistencia Medica ao Servidor Publico Estadual - IAMSPE [33]Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo [34]Hopital Nord [35]Institut Curie [36]Hopital PASTEUR [37]Universitaetsklinikum Giessen und Marburg GmbH [38]Thoraxklinik am Universitatsklinikum Heidelberg [39]Universitaetsklinikum der RWTH Aachen [40]Kliniken Essen-Mitte [41]Klinikum Kassel GmbH [42]Universitaetsklinikum Schleswig-Holstein Campus Kiel [43]Severance Hospital Yonsei University Health System [44]Chungbuk National University Hospital [45]Gachon University Gil Hospital [46]University Malaya Medical Centre [47]Hospital Umum Sarawak [48]Hospital Pulau Pinang [49]Hospital Tengku Ampuan Afzan [50]HOSP. GRAL. UNIV. DE ALICANTE [51]HOSP. NTRA. SRA. DE VALME [52]HOSP. UNIV. DE JAEN [53]HOSP. UNIV. LUCUS AUGUSTI [54]HOSP. UNIV. QUIRON DEXEUS [55]HOSP. GRAL. UNIV. GREGORIO MARANON [56]HOSP. UNIV. VALL D HEBRON [57]HOSP. GRAL. UNIV. DE ALICANTE [58]HOSP. UNIV. A CORUNA [59]Ankara Bilkent City Hospital [60]Gazi University Hospital [61]Adana City Hospital [62]Bakirkoy Training and Research Hospital [63]Ege University Medical Faculty [64]Ondokuz Mayis University [65]Gulhane Training and Research Hospital [66]I A U VM Medical Park Florya Hastanesi [67]Valley Medical Center [68]University Hospitals Cleveland Medical Center [69]Houston Methodist Cancer Center [70]Virginia Cancer Specialists [71]Gundersen Health System [72]Hunterdon Hematology Oncology [73]Clinical Research Alliance, Inc. [74]Cancer and Blood Specialty Clinic [75]Keck Hospital of USC [76]Kaiser Permanente Northern California [77]PIH Health Hospital [78]Hope and Healing Care [79]City of Hope Orange County Lennar Foundation Cancer Center [80]Renown Regional Medical Center [81]Providence Fullerton [82]North Shore Hematology Oncology Associates, P.C. [83]City of Hope [84]City of Hope Huntington Beach [85]City of Hope South Pasadena [86]City of Hope Long Beach Elm

研究目的:
主要目的是在接受Amivantamab和Lazertinib一线治疗的局部晚期或转移性IIIB/C-IV期EGFR突变NSCLC受试者中,评价与标准皮肤管理相比,加强皮肤管理是否可在第12周时降低≥2级DAEI的发生率。

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号